BioMarin Pharmaceutical Inc BMRN Balance Sheet

Biomarin pharmaceutical inc (BMRN)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Dec'09
ASSETS
Current assets:
Cash and cash equivalents
476	437	423	307	364	493	882	427	473	598	431	354	348	408	707	305	270	397	376	440	900	875	398	584	639	568	181	175	154	180	181	177	82	46	71	112	90	88	127	115	167
Short-term investments
381	316	297	423	530	590	561	935	908	797	825	372	329	381	327	197	186	195	241	240	108	69	268	251	247	215	198	225	247	267	245	224	150	148	153	145	161	186	224	221	133
Accounts receivable, net
396	377	402	377	393	342	384	363	318	261	251	238	230	215	215	214	180	164	148	186	175	144	121	122	110	117	124	115	120	109	117	100	105	104	107	106	106	86	78	77	73
Inventory
705	680	609	578	534	530	508	473	468	475	457	429	384	355	347	326	296	271	262	237	222	199	204	193	176	162	148	142	135	128	120	120	124	130	115	112	110	109	91	83	78
Current deferred tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30	31	31	-	29	30	30	30	32	29	29	32	-	-	-	21	-	-	-	-	-	-	-
Other current assets
155	130	126	119	93	98	71	80	71	74	83	62	60	61	68	61	58	60	115	77	84	108	56	37	41	41	28	33	35	25	54	58	50	18	39	36	34	33	31	22	14
Total current assets
2,116	1,942	1,859	1,806	1,916	2,056	2,407	2,280	2,241	2,207	2,050	1,458	1,352	1,421	1,666	1,105	992	1,089	1,175	1,213	1,522	1,397	1,077	1,220	1,246	1,137	713	720	723	743	719	681	513	469	487	514	503	504	554	521	467
Noncurrent assets:
Long-term investments
290	411	431	374	320	235	204	279	313	385	416	482	533	572	362	201	314	425	514	509	223	97	448	244	251	267	147	123	123	115	106	121	54	94	145	153	141	128	88	117	169
Investment in BioMarin/Genzyme LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	1	0	1	0	1	1	0	1	1	1	1	1	0	0
Property, plant and equipment, net
1,009	1,010	969	962	951	948	924	900	895	896	878	851	824	798	729	724	716	704	604	568	538	523	486	469	437	319	285	282	281	284	273	267	264	268	266	216	217	221	213	212	199
Intangible assets, net
443	456	462	476	485	491	494	502	509	517	530	538	546	553	561	568	1,177	683	920	923	926	156	159	163	165	163	165	168	172	162	165	168	170	180	100	101	102	103	104	77	40
Goodwill
196	197	197	197	197	197	197	197	197	197	197	197	197	197	197	197	197	197	202	202	202	54	54	54	54	54	54	54	54	51	51	51	51	51	51	53	53	53	53	40	23
Deferred tax assets
539	549	525	475	467	460	429	425	407	399	484	470	458	446	288	266	243	220	146	172	163	190	150	147	144	145	238	235	226	189	229	220	221	224	229	228	231	236	-	-	0
Other assets
125	122	112	99	96	36	37	39	32	29	22	21	26	32	36	23	25	408	60	58	80	54	61	46	41	156	14	14	15	19	19	20	19	15	13	12	12	14	228	14	15
Total assets
4,722	4,690	4,558	4,393	4,435	4,427	4,695	4,624	4,596	4,633	4,580	4,019	3,938	4,023	3,842	3,087	3,666	3,729	3,624	3,648	3,658	2,475	2,440	2,345	2,340	2,244	1,620	1,601	1,598	1,568	1,567	1,532	1,297	1,305	1,295	1,280	1,264	1,262	1,244	985	917
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
454	570	483	429	412	437	378	358	346	401	364	319	272	370	306	292	290	392	296	256	230	231	206	166	156	183	167	142	144	147	111	96	96	94	83	82	75	83	92	83	78
Short-term convertible debt, net
365	361	-	-	-	0	374	369	365	360	0	0	22	22	22	24	-	0	-	-	-	-	-	-	-	-	0	0	0	23	23	23	23	0	-	-	-	-	-	-	-
Short-term contingent consideration
-	-	10	9	88	85	86	76	61	53	52	55	45	46	48	47	97	52	94	91	75	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Total current liabilities
820	932	493	439	500	523	838	804	773	816	417	374	340	439	377	364	388	445	390	347	305	235	206	166	156	183	167	142	144	170	134	119	119	94	83	82	75	83	92	83	78
Noncurrent liabilities:
Long-term convertible debt, net
486	486	843	839	834	830	826	821	817	813	1,166	676	668	660	653	645	668	662	667	661	655	642	656	650	661	655	78	109	109	324	324	324	324	348	348	377	377	377	497	497	497
Long-term contingent consideration
50	50	48	50	48	46	58	57	137	135	126	122	116	115	122	120	135	32	34	37	39	38	42	40	38	30	26	23	27	30	-	-	-	33	-	-	-	-	-	-	-
Deferred tax liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	143	143	193	193	193	-	-	-	-	-	37	37	37	-	-	-	-	37	-	-	-	-	-	-	-
Other long-term liabilities
125	98	97	103	114	58	57	55	60	59	56	50	44	42	43	39	41	44	45	52	39	30	26	25	24	33	34	30	29	26	92	87	80	19	88	88	89	84	69	41	19
Total liabilities
1,482	1,567	1,483	1,432	1,498	1,459	1,780	1,739	1,789	1,824	1,767	1,224	1,169	1,257	1,196	1,169	1,376	1,328	1,332	1,291	1,233	947	931	883	880	903	344	343	348	552	552	532	525	532	520	548	543	545	658	622	594
Stockholders’ equity:
Common stock, $0.001 par value: 500,000,000 shares authorized; 180,761,969 and 179,383,114 shares issued and outstanding, respectively.
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital
4,854	4,832	4,782	4,744	4,682	4,669	4,620	4,577	4,510	4,483	4,435	4,397	4,314	4,288	4,231	3,458	3,410	3,414	3,371	3,337	3,308	2,359	2,278	2,249	2,213	2,059	1,926	1,863	1,833	1,561	1,505	1,483	1,221	1,197	1,175	1,122	1,103	1,090	948	931	899
Company common stock held by Nonqualified Deferred Compensation Plan (the NQDC)
9	9	9	10	12	13	13	13	14	14	14	14	14	14	14	14	13	13	13	13	9	9	9	10	6	7	7	7	5	6	6	6	3	3	3	3	1	1	2	2	1
Accumulated other comprehensive income
34	20	37	17	19	5	-2	-1	-28	-22	-21	-14	5	12	2	4	0	21	25	32	43	27	19	9	7	5	11	2	1	-0	2	4	2	4	1	-5	-5	0	-1	10	0
Accumulated deficit
-1,639	-1,720	-1,735	-1,790	-1,753	-1,694	-1,690	-1,677	-1,661	-1,637	-1,586	-1,573	-1,536	-1,520	-1,573	-1,530	-1,106	-1,021	-1,090	-999	-917	-849	-779	-787	-753	-715	-653	-600	-579	-539	-486	-481	-449	-425	-398	-380	-375	-371	-359	-576	-577
Total stockholders’ equity
3,239	3,122	3,074	2,960	2,936	2,967	2,914	2,885	2,807	2,808	2,813	2,795	2,769	2,766	2,645	1,917	2,290	2,400	2,292	2,356	2,425	1,527	1,508	1,461	1,460	1,341	1,276	1,258	1,250	1,015	1,015	1,000	771	773	774	732	720	717	585	362	322
Total liabilities and stockholders’ equity
4,722	4,690	4,558	4,393	4,435	4,427	4,695	4,624	4,596	4,633	4,580	4,019	3,938	4,023	3,842	3,087	3,666	3,729	3,624	3,648	3,658	2,475	2,440	2,345	2,340	2,244	1,620	1,601	1,598	1,568	1,567	1,532	1,297	1,305	1,295	1,280	1,264	1,262	1,244	985	917